Showing 1-10 of 18 grants

Title Institution Researcher Program Duration Total Award Amount
Dock2-mediated T cell migration as a targetable shared mechanism in autoimmunity University of Pittsburgh Alok Joglekar Cures 01-September-2025 to 31-August-2026 $149,999.05
Defining the Antigenic Landscape of Islet-Infiltrating T cells in Type 1 Diabetes University of Pittsburgh Alok Joglekar Cures 01-March-2023 to 28-February-2026 $900,000.00
Targeting self-RNA sensing as a trigger of inflammation in type 1 diabetes Trustees of the University of Pennsylvania Qin Li Cures 01-April-2025 to 31-March-2026 $199,919.54
Targeted mRNA LNP strategies to modulate lymphocyte migration and Treg function for T1D immunotherapy Trustees of the University of Pennsylvania Michael Betts Cures 01-September-2024 to 31-August-2027 $900,000.00
Mapping islet-reactive T cell responses by islet cell co-culture Trustees of the University of Pennsylvania Michael Betts Cures 01-July-2022 to 30-June-2025 $825,000.00
T1 TRIDENT / Transformative Research in Diabetic Nephropathy Trustees of the University of Pennsylvania Katalin Susztak Improving Lives 01-September-2019 to 30-September-2024 $191,795.06
An AI-driven bioelectronics system to accelerate SC-islet maturation Trustees of the University of Pennsylvania Juan Alvarez Cures 01-April-2025 to 31-March-2026 $200,000.00
Evaluating gene-modified hypo-immune PSCs for immune evasion in NHPs Trustees of the University of Pennsylvania Ji Lei Cures 01-June-2025 to 31-May-2027 $749,999.08
Pancreatic Lymph Node T cell Composition and Function in Human Type 1 Diabetes Trustees of the University of Pennsylvania Gregory Golden Cures 01-April-2023 to 31-March-2026 $214,356.00
Inhibition of REDD1 Allostery as a Therapeutic for Type 1 Diabetes Penn State College of Medicine Michael Dennis Improving Lives 01-June-2024 to 31-May-2026 $200,000.00